TYRISA

Welcome to the Brand page for “TYRISA”, which is offered here for In the statement, column 1, lines 6-14, pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiovascular, genitourinary, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric is deleted, and pharmaceutical preparations and substances for the treatment of cardiovascular related diseases is inserted, and, in the statement, column 2, lines 1-2, related diseases and disorders and skin and tissue repair preparations is deleted.;[ pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiovascular, genitourinary, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations ] * pharmaceutical preparations and substances for the treatment of cardiovascular related diseases *;.

Its status is currently believed to be active. Its class is unavailable. “TYRISA” is believed to be currently owned by “GLAXO GROUP LIMITED”.